Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004;2004(1):CD003958.
doi: 10.1002/14651858.CD003958.pub2.

Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise

M Paradisis  1 , D A Osborn
Affiliations

Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise

M Paradisis et al. Cochrane Database Syst Rev. 2004.

Abstract

Background: Inotropes are widely used in preterm infants to treat cardiovascular compromise, which may result from early adaptive problems of the transitional circulation, perinatal asphyxia or sepsis. Sustained hypotension and poor organ blood flow are associated with brain injury including peri/intraventricular haemorrhage and subsequent poor neurodevelopmental outcomes. Adrenaline (epinephrine) infusions are used in preterm infants with clinical cardiovascular compromise.

Objectives: To determine the effectiveness and safety of adrenaline compared to no treatment or other inotropes in reducing mortality and morbidity in preterm infants with cardiovascular compromise.

Search strategy: Randomised controlled trials were identified by searching MEDLINE (1966-August 2003), The Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 3, 2003) and EMBASE (1980 - 2003), supplemented with searches of reference lists of published trials and abstracts of conference proceedings.

Selection criteria: Randomised controlled trials of preterm newborn infants that compared adrenaline to no treatment or other inotropic agents (including dopamine, dobutamine, noradrenaline or isoprenaline).

Data collection and analysis: Data were extracted and analysed independently by two reviewers. Treatment effects on the following outcomes were to be determined: mortality in the newborn period, long term neurodevelopmental outcomes, radiological evidence of brain injury, short term haemodynamic changes, adverse drug effects and short term neonatal outcomes. Study authors were contacted for additional information. Studies were analysed for methodological quality using the criteria of the Cochrane Neonatal Review Group.

Main results: One ongoing study (Pellicer 2003) was identified. One study comparing adrenaline with dopamine infusion was included but was published in abstract form only (Phillipos 1996). It enrolled hypotensive, predominantly preterm infants in the first 24 hours. Only infants >1750g are included in this review (report for infants <=1750g appears incomplete). The study was reported as being randomised and double blinded, but methods were not reported. Both adrenaline and dopamine significantly increased heart rate and mean BP, with no statistically significant effect on left or right ventricular outputs. No other clinical outcomes were reported. No studies were identified that compared adrenaline to other inotropes, placebo or no treatment.

Reviewer's conclusions: There are insufficient data on the use of adrenaline infusions in preterm infants with cardiovascular compromise to make recommendations for practice. There is a need for larger trials to determine whether adrenaline is effective in reducing morbidity and mortality in preterm infants with cardiovascular compromise.

PubMed Disclaimer

Conflict of interest statement

Both the authors are investigators in trials of cardiovascular interventions in preterm infants.

Update of

  • doi: 10.1002/14651858.CD003958

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Phillipos 1996 {published data only}
    1. Phillipos EZ, Barrington KJ, Robertson MA. Dopamine versus epinephrine for inotropic support in the neonate: A randomized double blinded controlled trial. Pediatric Research 1996;39:238A.
    1. Phillipos EZ, Barrington KJ, Robertson MA. The effects of dopamine vs epinephrine on the pulmonary circulation in the sick newborn: A randomized double blinded controlled trial. Pediatric Research 1996;39:238A.
    1. Phillipos EZ, Robertson MA. A randomized blinded trial of dopamine versus epinephrine for inotropic support in the sick newborn. Proceedings of the 2nd World Congress of PCCS. 1997:897‐9.
    1. Phillipos EZ, Robertson MA. A randomized double blinded controlled trial of dopamine vs epinephrine for inotropic support in premature infants <1750 grams. Pediatric Research 2000;47:425A.
    1. Phillipos EZ, Robertson MA. A randomized double blinded controlled trial of dopamine vs epinephrine on pulmonary artery pressure in premature infants < 1750 grams. Pediatric Research 2000;47:425A.

References to ongoing studies

Pellicer 2003 {published and unpublished data}
    1. Pellicer A, Valverde E, Elorza MD, Madero R, Gaya F, Quero J, Cababnas F. Randomized blinded controlled trial on the effects on brain hemodynamics of dopamine v epinephrine for inotropic support in preterm infants. Pediatric Academic Societies Annual Meeting 2003:2364A.

Additional references

Bada 1990
    1. Bada HS, Korones SB, Perry EH, Arheart KL, Ray JD, Pourcyrous M, Magill HL, Runyan W 3rd, Somes GW, Clark FC, et al. Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage. Journal of Pediatrics 1990;117:607‐14. - PubMed
Barrington 1993
    1. Barrington K, Chan W. The circulatory effects of epinephrine infusion in the anesthetized piglet. Pediatric Research 1993;33:190‐4. - PubMed
Barrington 1995
    1. Barrington KJ, Finer NN, Chan WKY. A blind, randomized comparison of the circulatory effects of dopamine and epinephrine infusions in the newborn piglet during normoxia and hypoxia. Critical Care Medicine 1995;23:740‐8. - PubMed
Campbell 1998
    1. Campbell ME, Byrne PJ. Outcome after intravenous epinephrine infusion in infants <750g. Pediatric Research 1998;43:209A.
Cheung 1997
    1. Cheung PY, Barrington KJ, Pearson RJ, Bigam DL, Finer NN, Aerde J. Systemic, pulmonary, and mesenteric perfusion and oxygenation effects of dopamine and epinephrine. American Journal of Respiratory and Critical Care Medicine 1997;155:32‐7. - PubMed
Derleth 1997
    1. Derleth DP. Clinical experience with norepinephrine infusions in critically ill newborns. Pediatric Research 1997;40:145A.
Gill 1993
    1. Gill AB, Weindling AM. Echocardiographic assessment of cardiac function in shocked very low birthweight infants. Archives of Disease in Childhood 1993;68:17‐21. - PMC - PubMed
Goldstein 1995
    1. Goldstein RF, Thompson RJ Jr, Oehler JM, Brazy JE. Influence of acidosis, hypoxemia and hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics 1995;95:238‐43. - PubMed
Hunt 2001
    1. Hunt RW, Evans N, Rieger I, Kluckow M. Low superior vena cava flow in the first 24 hours of life and 3 year neurodevelopmental outcome. Pediatric Research 2001;49:336A.
Kluckow 1996
    1. Kluckow M, Evans N. Relationship between blood pressure and cardiac output in preterm infants requiring mechanical ventilation. Journal of Pediatrics 1996;129:506‐12. - PubMed
Kluckow 2000
    1. Kluckow M, Evans N. Low superior vena cava flow and intraventricular haemorrhage in preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition 2000;82:F188‐94. - PMC - PubMed
Kluckow 2001
    1. Kluckow M, Evans N. Low systemic blood flow in the preterm infant. Semin Neonatol 2001;6:75‐84. - PubMed
Lundstrom 2000
    1. Lundstrom K, Pryds O, Greisen G. The haemodynamic effects of dopamine and volume expansion in sick preterm infants. Early Human Development 2000;57:157‐63. - PubMed
Meek 1999
    1. Meek J, Tyszczuk L, Elwell CE, Wyatt JS. Low cerebral blood flow is a risk factor for severe intraventricular haemorrhage. Archives of Disease in Childhood. Fetal and Neonatal Edition 1999;81:F15‐F18. - PMC - PubMed
Miall‐Allen 1987
    1. Miall‐Allen VM, Vries LS, Whitelaw AG. Mean arterial blood pressure and neonatal cerebral lesions. Archives of Disease in Childhood 1987;62:1068‐9. - PMC - PubMed
Murphy 1997
    1. Murphy DJ, Hope P, Johnson A. Neonatal risk factors for cerebral palsy in very preterm babies: case‐control study. BMJ 1997;314:404‐8. - PMC - PubMed
Osborn 2002a
    1. Osborn DA, Evans N, Kluckow M. Left ventricular contractility and wall stress in very preterm infants in the first day of life. Pediatric Research 2002;51:386A. - PubMed
Osborn 2002b
    1. Osborn D, Evans N, Kluckow M. Randomised trial of dobutamine versus dopamine in preterm infants with low systemic blood flow. Journal of Pediatrics 2002;140:183‐91. - PubMed
Osborn 2002c
    1. Osborn DA, Evans N. Early volume expansion for prevention of morbidity and mortality in very preterm infants (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 3. - PubMed
Osborn 2002d
    1. Osborn DA, Evans N. Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm infants (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD002056] - DOI - PMC - PubMed
Osborn 2003
    1. Osborn DA, Evans N, Kluckow M. Haemodynamic and antecedent risk factors of early and late periventricular/intraventricular hemorrhage in premature infants. Pediatrics 2003;112:33‐39. - PubMed
Padbury 1987
    1. Padbury JF, Agata Y, Baylen BG, Ludlow JK, Polk DH, Goldblatt E, Pescetti J. Dopamine pharmacokinetics in critically ill newborn infants. Journal of Pediatrics 1987;110:293‐98. - PubMed
Perkin 1982
    1. Perkin RM, Levin DL. Shock in the pediatric patient. Part II. Therapy. Journal of Pediatrics 1982;101:319‐32. - PubMed
Roze 1993
    1. Roze JC, Tohier C, Maingueneau C, Lefevre M, Mouzard A. Response to dobutamine and dopamine in the hypotensive very preterm infant. Archives of Disease in Childhood 1993;69:59‐63. - PMC - PubMed
Seri 1995
    1. Seri I. Cardiovascular, renal and endocrine actions of dopamine in neonates and children. J Pediatr 1995;126:333‐44. - PubMed
Seri 1998a
    1. Seri I, Evans J. Addition of epinephrine to dopamine increases blood pressure and urine output in critically ill extremely low birth weight neonates with uncompensated shock. Pediatric Research 1998;43:194A.
Seri 1998b
    1. Seri I, Abbasi S, Wood DC, Gerdes JS. Regional hemodynamic effects of dopamine in the sick preterm neonate. Journal of Pediatrics 1998;133:728‐34. - PubMed
Seri 2001
    1. Seri I. Circulatory support of the sick preterm infant. Semin Neonatol 2001;6:85‐95. - PubMed
Subhedar 2002
    1. Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD001242] - DOI - PubMed
Venkataraman 1984
    1. Venkataraman PS, Babcock DS, Tsang RC, Ballard JL. Hepatic injury: a possible complication of dopamine infusion through an inappropriately placed umbilical vein catheter. American Journal of Perinatology 1984;1:351‐54. - PubMed
Versmold 1981
    1. Versmold HT, Kitterman JA, Phibbs RH, Gregory GA. Tooley WH. Aortic blood pressure during the first 12 hours of life in infants with birth weight 610 to 4,220 grams. Pediatrics 1981;67:607‐13. - PubMed
Whitelaw 2002
    1. Whitelaw A, Ogbureke K, Subhedar N. Corticosteroids for hypotension in preterm infants (Protocol for a Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 3.
Zaritsky 1984
    1. Zaritsky A, Chernow B. Use of catecholamines in pediatrics. Journal of Pediatrics 1984;105:341‐50. - PubMed

Publication types

MeSH terms